PIUR IMAGING

Executive Summary

PIUR IMAGING is an Austrian medical technology company founded in 2015 that is revolutionizing ultrasound diagnostics with its AI-powered, vendor-agnostic software platform, PIUR tUS Infinity. By upgrading existing ultrasound systems, the platform automates image annotation, analysis, and reporting, significantly streamlining clinical workflows. The company focuses on high-impact applications such as thyroid imaging and carotid plaque analysis, addressing critical needs in non-invasive diagnostics. With a lean, capital-efficient model and no disclosed funding rounds, PIUR is positioned to scale through partnerships and regulatory clearances. Its technology has the potential to democratize access to advanced ultrasound analysis, particularly in resource-limited settings, by eliminating the need for expensive hardware upgrades. The company's private status and limited public information suggest a focus on product development and early-stage commercialization, with a strong emphasis on clinical validation and market penetration in Europe and potentially the United States. Given the growing adoption of AI in medical imaging and the global demand for cost-effective diagnostic solutions, PIUR IMAGING represents a compelling opportunity in the medtech space, albeit with execution risks typical of early-stage ventures.

Upcoming Catalysts (preview)

• Q4 2026FDA 510(k) clearance for PIUR tUS Infinity in the U.S.60% success
• Q2 2026Publication of pivotal clinical study results for carotid plaque analysis70% success
• Q3 2026Strategic partnership with a major ultrasound manufacturer (e.g., GE, Philips, Siemens)40% success